Ciprofloxacin Medicinal Tablets 250MG 500MG 750MG Antibiotic 10*1's
Ciprofloxacin Tablets 500MG
Each Ciprofloxacin Tablets contains ciprofloxacin 500mg.
Fluoroquinolones bring about their bactericidal action by
inhibiting the bacterial DNA gyrase enzyme. DNA gyrase is
responsible for continuous introduction of negative supercoils into
DNA. This is an ATP dependent reaction that requires both strands
of the DNA to be cut to permit passage of a segment of DNA through
the break; the break is then resealed. Fluoroquinolones decrease
the introduction of negative supercoils into DNA and cause rapid
cessation of DNA synthesis by interfering with the propagation of
The antibacterial spectrum of ciprofloxacin includes Gram-negative
and Gram-positive organisms viz.
Ciprofloxacin is well absorbed when given orally with a
bioavailability of 70%. The mean peak plasma concentrations
achieved after oral administration of 250 mg, 500 mg and 750 mg of
ciprofloxacin are 1.2 mcg/mL, 2.4 mcg/mL and 4.3 mcg/mL
respectively, achieved within 1-2 hours of administration.
Absorption is delayed when ciprofloxacin is given with a meal.
Ciprofloxacin is indicated for the treatment of the following
infections caused by ciprofloxacin sensitive bacteria:
Lower Respiratory Tract Infections
Urinary Tract Infections
Skin and Soft Tissue Infections
In the treatment of infections caused by Pseudomonas aeruginosa, an aminoglycoside must be administered concomitantly.
Safety during pregnancy and lactation has not been established.
Ciprofloxacin is contra-indicated in children under 18 years and in
growing adolescents, except where the benefits of treatment exceed
the risks. Experimental evidence indicates that, species variable,
reversible lesions of the cartilage of weight bearing joints has
been seen in immature members of certain animal species.
Ciprofloxacin is contra-indicated in patients who have shown
hypersensitivity to ciprofloxacin or any other quinolones.
Ciprofloxacin should be used with caution in patients with a
history of convulsive disorders.
Crystalluria related to the use of ciprofloxacin has been observed.
Patients receiving ciprofloxacin should be well hydrated and
excessive alkalinity of the urine should be avoided.
DOSAGE AND DIRECTIONS FOR USE:
Ciprofloxacin tablets should be swallowed whole with plenty of
liquid and may be taken with or without meals.
Dosage and duration of treatment: The dosage range is 250-750 mg
The duration of treatment depends upon the severity of the
infection, clinical response and bacteriological findings.
Infections of the lower respiratory tract: Mild to moderate - 250
to 500 mg twice daily; severe or complicated - 750 mg twice daily.
In cystic fibrosis patients the dose is 750 mg twice daily. The low
body mass of these patients should, however, be taken into
consideration when determining dosage (7.5 to 15 mg/kg/day).
Infectious diarrhoea: 500 mg twice daily.
Infections of the urinary tract: Acute uncomplicated cystitis - 250
mg twice daily; mild to moderate - 250 mg twice daily; severe or
complicated - 500 mg twice daily.
Infections of the skin: Mild to moderate - 500 mg twice daily;
severe or complicated - 750 mg twice daily.
Bone infections: Mild to moderate 500 mg twice daily; severe or
complicated - 750 mg twice daily. Treatment may be required for 4-6
weeks or longer.
Gonorrhoea: A single dose of 250 mg.
Elderly patients should receive a dose as low as possible; this
will depend on the severity of the illness and on the creatinine
Impaired renal or liver function: In patients with reduced renal
function, the half-life of ciprofloxacin is prolonged and the
dosage needs to be adjusted.
SIDE EFFECTS AND SPECIAL PRECAUTIONS:
Effects on the gastro-intestinal tract: Nausea, diarrhoea, vomiting, dyspepsia, abdominal pain,
Effects on the nervous system: Dizziness, headache, tiredness, nervousness, agitation,
Reactions of sensory organs
Store below 25°C, protected from moisture.
KEEP OUT OF REACH OF CHILDREN.